Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2

Molnupiravir (EIDD-2801/MK-4482), the prodrug of the active antiviral ribonucleoside analog β-d-N4-hydroxycytidine (NHC; EIDD-1931), has activity against a number of RNA viruses, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SA...

Descripción completa

Detalles Bibliográficos
Autores principales: Painter, Wendy P., Holman, Wayne, Bush, Jim A., Almazedi, Firas, Malik, Hamzah, Eraut, Nicola C. J. E., Morin, Merribeth J., Szewczyk, Laura J., Painter, George R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Antiviral Agents
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092915/
https://www.ncbi.nlm.nih.gov/pubmed/33649113
http://dx.doi.org/10.1128/AAC.02428-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092915/
https://www.ncbi.nlm.nih.gov/pubmed/33649113
http://dx.doi.org/10.1128/AAC.02428-20

Ejemplares similares